Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-118 Lotion in Pediatric Plaque Psoriasis
NCT03988439Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Mar 2021
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, open-label, single-arm trial of IDP-118 Vehicle Lotion in plaque psoriasis, sponsored by Valeant Pharmaceuticals. Primary endpoint: Maximum Observed Drug Concentration in Plasma at 24 hours. Started Mar 2021; status: completed.
02
Drugs
IDP-118 Vehicle Lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03988439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03988439.